|
Name |
cyclo[Asp-D-Leu-Leu-ObAla(3-isododecyl)-Glu-Leu-D-Leu-Val]
|
Molecular Formula | C53H93N7O13 | |
IUPAC Name* |
3-[(3S,6R,9S,12S,15R,18S,21S)-9-(carboxymethyl)-3,6,15,18-tetrakis(2-methylpropyl)-25-(10-methylundecyl)-2,5,8,11,14,17,20,23-octaoxo-12-propan-2-yl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-21-yl]propanoic acid
|
|
SMILES |
CC(C)CCCCCCCCCC1CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)O1)CC(C)C)CC(C)C)CC(=O)O)C(C)C)CC(C)C)CC(C)C)CCC(=O)O
|
|
InChI |
InChI=1S/C53H93N7O13/c1-30(2)20-18-16-14-13-15-17-19-21-36-28-43(61)54-37(22-23-44(62)63)47(66)55-38(24-31(3)4)48(67)57-40(26-33(7)8)51(70)60-46(35(11)12)52(71)58-41(29-45(64)65)50(69)56-39(25-32(5)6)49(68)59-42(27-34(9)10)53(72)73-36/h30-42,46H,13-29H2,1-12H3,(H,54,61)(H,55,66)(H,56,69)(H,57,67)(H,58,71)(H,59,68)(H,60,70)(H,62,63)(H,64,65)/t36?,37-,38-,39+,40+,41-,42-,46-/m0/s1
|
|
InChIKey |
NJGWOFRZMQRKHT-VKBYPPDESA-N
|
|
Synonyms |
Surfactin; 24730-31-2
|
|
CAS | 24730-31-2 | |
PubChem CID | 10129764 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 1036.3 | ALogp: | 8.8 |
HBD: | 9 | HBA: | 13 |
Rotatable Bonds: | 24 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 305.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 73 | QED Weighted: | 0.043 |
Caco-2 Permeability: | -5.75 | MDCK Permeability: | 0.00009190 |
Pgp-inhibitor: | 0.29 | Pgp-substrate: | 0.99 |
Human Intestinal Absorption (HIA): | 0.025 | 20% Bioavailability (F20%): | 0.97 |
30% Bioavailability (F30%): | 0.934 |
Blood-Brain-Barrier Penetration (BBB): | 0.006 | Plasma Protein Binding (PPB): | 95.51% |
Volume Distribution (VD): | 0.398 | Fu: | 3.86% |
CYP1A2-inhibitor: | 0 | CYP1A2-substrate: | 0.003 |
CYP2C19-inhibitor: | 0.05 | CYP2C19-substrate: | 0.036 |
CYP2C9-inhibitor: | 0.159 | CYP2C9-substrate: | 0.998 |
CYP2D6-inhibitor: | 0.028 | CYP2D6-substrate: | 0.027 |
CYP3A4-inhibitor: | 0.255 | CYP3A4-substrate: | 0.045 |
Clearance (CL): | 2.142 | Half-life (T1/2): | 0.747 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.973 |
Drug-inuced Liver Injury (DILI): | 0.155 | AMES Toxicity: | 0.002 |
Rat Oral Acute Toxicity: | 0.093 | Maximum Recommended Daily Dose: | 0.93 |
Skin Sensitization: | 0.136 | Carcinogencity: | 0.068 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.004 |
Respiratory Toxicity: | 0.023 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002910 | 0.969 | D0K7NQ | 0.446 | ||||
ENC003254 | 0.485 | D0J7XL | 0.403 | ||||
ENC005273 | 0.482 | D09OOV | 0.384 | ||||
ENC002094 | 0.455 | D0Q3BV | 0.362 | ||||
ENC005275 | 0.452 | D0M1IO | 0.357 | ||||
ENC003247 | 0.449 | D07FEC | 0.356 | ||||
ENC001506 | 0.440 | D05HPI | 0.337 | ||||
ENC005271 | 0.439 | D0O3YF | 0.327 | ||||
ENC003950 | 0.436 | D0L9HX | 0.324 | ||||
ENC005272 | 0.432 | D06TFE | 0.299 |